This company is already the result of a merger between Eclipsys (which focuses on hospitals and health care organizations) and the previous Allscripts (which focused on physician offices). The problem is lack of integration between their products.
My prediction is that they will move more into population health and patient/clinician portals, potentially replacing revenue from hospitals jumping ship for more integrated solutions. Of course, those other companies are improving their products in the pop health, portals and capabilities to handle transitions of care. I would not recommend Allscripts at this time because their future is murkier than their competitors, and more importantly, this stock has languished for years without upward momentum.